Dr. Nikiforov on Reclassifying Subtype of Thyroid Cancer | OncLive

Dr. Nikiforov on Reclassifying Subtype of Thyroid Cancer

March 3, 2017

Yuri E. Nikiforov, MD, PhD, professor of Pathology, vice chair of the Department of Pathology, director, Division of Molecular & Genomic Pathology, University of Pittsburgh, discusses research that demonstrated the need to reclassify a subtype of thyroid cancer as not cancerous.

Yuri E. Nikiforov, MD, PhD, professor of Pathology, vice chair of the Department of Pathology, director, Division of Molecular & Genomic Pathology, University of Pittsburgh, discusses research that demonstrated the need to reclassify a subtype of thyroid cancer as not cancerous.

Some subtypes of thyroid cancer are indolent while others are very aggressive, Nikiforov explains. However, a certain type of thyroid cancer is very indolent and rarely causes harm to patients. While conducting long-term folllow-up of this specific patient population, research concluded that most of the patients lived a normal live and did not experience any adverse outcomes associated with the disease.

Therefore, the name is suggested to be reclassified as noninvasive follicular tumors, also known as a noninvasive follicular thyroid neoplasm with papillary-like nuclear features. They will no longer be labeled with the term cancer, he adds.


x